Joseph R. Young

CIK: 0001861684

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VERA

Vera Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

VERA
Vera Therapeutics, Inc.
Sep 11, 2026
Exercise(M)
Direct
5K shares at avg. $3.94$20K
VERA
Vera Therapeutics, Inc.
Mar 13, 2026
Exercise(M)
Direct
10K shares at avg. $3.94$39K
VERA
Vera Therapeutics, Inc.
Feb 23, 2026
Sale(S)
Direct
3.1K shares at avg. $41.98$131K
VERA
Vera Therapeutics, Inc.
Feb 4, 2026
Award(A)
Direct
10K shares-
VERA
Vera Therapeutics, Inc.
Nov 13, 2025
Exercise(M)
Direct
10K shares at avg. $3.94$39K
VERA
Vera Therapeutics, Inc.
Nov 11, 2025
Sale(S)
Direct
15K shares at avg. $29.06$436K
VERA
Vera Therapeutics, Inc.
Feb 18, 2025
Award(A)
Direct
10.7K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	VERA Vera Therapeutics, Inc.	Exercise(M)	5,000	$3.94	$19,698	Direct
Mar 13, 2026	VERA Vera Therapeutics, Inc.	Exercise(M)	10,000	$3.94	$39,396	Direct
Feb 23, 2026	VERA Vera Therapeutics, Inc.	Sale(S)	3,117	$41.98	$130,864	Direct
Feb 4, 2026	VERA Vera Therapeutics, Inc.	Award(A)	10,000	-	$0	Direct
Nov 13, 2025	VERA Vera Therapeutics, Inc.	Exercise(M)	10,000	$3.94	$39,396	Direct
Nov 11, 2025	VERA Vera Therapeutics, Inc.	Sale(S)	15,000	$29.06	$435,875	Direct
Feb 18, 2025	VERA Vera Therapeutics, Inc.	Award(A)	10,740	-	-	Direct

1-7 of 7 transactions

About Young Joseph R

Young Joseph R (SEC CIK 0001861684) files insider reports with the SEC as SVP, FINANCE, CHIEF ACCT OFFCR of Vera Therapeutics, Inc. (VERA).

Signal8 holds 6 ownership filings by Young Joseph R, all Form 4s, filed between Feb 20, 2025 and Sep 14, 2026. Those filings report 7 transactions, from Feb 18, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Young Joseph R's filings is in BRISBANE, CA.

Recent filings by Young Joseph R

Sep 11, 2026: Option exercise of VERA shares (Form 4, code M).
Mar 13, 2026: Option exercise of VERA shares (Form 4, code M).
Feb 23, 2026: Open-market sale of VERA shares (Form 4, code S).
Feb 4, 2026: Grant or award of VERA shares (Form 4, code A).
Nov 13, 2025: Option exercise of VERA shares (Form 4, code M).

Other insiders filing for Vera Therapeutics, Inc. (VERA)

Fordyce Marshall, PRESIDENT AND CEO
Boman Nancy Lee, Chief Regulatory Officer
Morrison Scott W, Director
Cheng Andrew, Director
SEIDENBERG BETH C, Director
Oliger Christy J., Director

How to read Form 4 transaction codes